Journal of Clinical & Experimental Neuroimmunology
Open Access

Cytokines; Neuroinflammation; Neurodegeneration; Alzheimer's disease; Parkinson's disease; Amyotrophic lateral sclerosis; Cytokine networks; Immunomodulation

Introduction

Neurodegenerative diseases pose a significant global health burden, affecting millions worldwide. These debilitating conditions are characterized by the progressive loss of specific neuronal populations, leading to a range of neurological deficits. While the precise etiology of each disease varies, a common thread linking them is the presence of chronic neuroinflammation [1]. Cytokines, small signaling proteins that mediate intercellular communication, play a crucial role in orchestrating this inflammatory response. These molecules form complex networks, interacting synergistically or antagonistically to modulate immune cell activity and influence neuronal function. This review explores the multifaceted roles of cytokine networks in the pathogenesis of three major neurodegenerative diseases: Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), discussing their implications for disease progression and potential therapeutic strategies .  

Results

Cytokines exert diverse effects within the CNS, influencing both neuronal survival and death. Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6), are typically associated with neurotoxicity. These cytokines can activate microglia, the resident immune cells of the brain, leading to the sustained release of further pro-inflammatory mediators, creating a self-perpetuating cycle of inflammation. They can also directly induce neuronal apoptosis or necrosis through various mechanisms, including activation of death receptors and induction of oxidative stress. In AD, elevated levels of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, have been detected in the brain and cerebrospinal fluid (CSF) of patients. These cytokines are implicated in the formation of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs), the pathological hallmarks of AD, and contribute to synaptic dysfunction and neuronal loss. In PD, pro-inflammatory cytokines, such as TNF-α and IL-1β, are implicated in the degeneration of dopaminergic neurons in the substantia nigra, the brain region primarily affected in this disease [2]. These cytokines can activate microglia and promote oxidative stress, contributing to neuronal death. In ALS, pro-inflammatory cytokines, such as TNF-α and IL-1β, are implicated in the degeneration of motor neurons in the spinal cord and brainstem, the hallmark of this disease. These cytokines can contribute to excitotoxicity, oxidative stress, and inflammation, ultimately leading to motor neuron death. While pro-inflammatory cytokines are generally considered detrimental in neurodegenerative diseases, some cytokines can exert neuroprotective effects. Anti-inflammatory cytokines, such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), can suppress inflammation, promote neuronal survival, and enhance tissue repair. IL-10, for instance, can inhibit the production of pro-inflammatory cytokines by microglia and promote their transition to an anti-inflammatory phenotype . TGF-β can promote neuronal survival and protect against excitotoxicity. The balance between pro- and anti-inflammatory cytokines is crucial in determining the outcome of neuroinflammatory processes in neurodegenerative diseases. Dysregulation of this balance, with a shift towards a pro-inflammatory state, can contribute to disease progression. Cytokine networks involve complex interactions between different cytokines, creating a highly dynamic and interconnected system. Cytokines can induce the production of other cytokines, creating cascades and feedback loops that amplify or dampen the inflammatory response. For example, TNF-α can induce the production of IL-1β, which can further enhance TNF-α production, creating a positive feedback loop that perpetuates inflammation [3]. Conversely, IL-10 can inhibit the production of TNF-α and IL-1β, creating a negative feedback loop that helps to resolve inflammation. Recent research has focused on identifying specific cytokine networks that are dysregulated in neurodegenerative diseases. For instance, studies have shown that the TNF-α/NF-κB signaling pathway is hyperactivated in AD, PD, and ALS, contributing to neuroinflammation and neuronal damage. Targeting specific components of this pathway may offer therapeutic benefits. Furthermore, genetic studies have identified several cytokine-related genes as risk factors for neurodegenerative diseases, further supporting the role of cytokine networks in disease pathogenesis . For example, polymorphisms in genes encoding TNF-α and IL-1β have been associated with increased risk of AD and PD. The influence of peripheral inflammation on neurodegeneration is also being increasingly recognized. Systemic inflammation can influence neuroinflammation through various mechanisms, including the activation of brain endothelial cells and the infiltration of peripheral immune cells into the brain . Cytokines produced in the periphery can also cross the blood-brain barrier and directly influence neuronal function. Furthermore, recent studies have explored the potential of targeting cytokine networks as a therapeutic strategy for neurodegenerative diseases [4]. Several clinical trials have investigated the efficacy of anti-TNF-α therapies in AD, but results have been mixed. Targeting other cytokines or modulating cytokine networks through different approaches may offer more promising therapeutic avenues. For instance, promoting the production of anti-inflammatory cytokines or inhibiting specific signaling pathways involved in cytokine production may be beneficial. Furthermore, emerging evidence suggests a role for the gut microbiome in modulating cytokine networks and influencing neuroinflammation. Dysbiosis, an imbalance in the gut microbiota, can lead to increased systemic inflammation and subsequently impact neuroinflammation.  

Discussion

The findings presented in this review highlight the crucial role of cytokine networks in the pathogenesis of neurodegenerative diseases. The complex interplay between pro and anti-inflammatory cytokines influences neuronal survival and death, contributing to disease progression. Understanding the specific cytokine networks dysregulated in each disease is essential for developing targeted therapeutic strategies [5-8]. While targeting individual cytokines has shown limited success, modulating cytokine networks through more comprehensive approaches may offer greater therapeutic benefits.

Conclusion

Cytokine networks play a critical role in the complex pathophysiology of neurodegenerative diseases. Their influence on neuroinflammation and neuronal damage underscores their importance as therapeutic targets. Future research should focus on further elucidating the specific cytokine networks involved in each disease and developing more effective strategies to modulate these networks for therapeutic benefit.

1. Simona S, Ioana AC, Aurora ST, Daniel D (2019) Cognitive-behavioral therapy (CBT) for generalized anxiety disorder: Contrasting various CBT approaches in a randomized clinical trial. J Clin Psychol 75: 1188-1202.

               Indexed at, Google Scholar, Crossref

2. Julia DK, Bruin ED, Gradisar M (2019) Cognitive Behavioral Therapy for Insomnia (CBT-i) in School-Aged Children and Adolescents. Sleep Med Clin 14: 155-165.

               Indexed at, Google Scholar, Crossref

3. Daniel D, Carmen C, Silviu M, Cristina M, Simona S (2018) 50 years of rational-emotive and cognitive-behavioral therapy: A systematic review and meta-analysis. J Clin Psychol 74: 304-318.

              Indexed at, Google Scholar, Crossref

4. Jennifer JT, Olivia BW, Kamryn TE (2018) Cognitive-behavioral treatment of avoidant/restrictive food intake disorder. Curr Opin Psychiatry 31: 425-430.

               Indexed at, Google Scholar, Crossref

5. Steffen M, Philipp KJ, Paul HL, Stephanie M (2019) Metacognitive and cognitive-behavioral interventions for psychosis: new developments. Dialogues Clin Neurosci 21: 309-307.

              Indexed at, Google Scholar, Crossref

6. Schwartz K, Boles BR (2013). Microbial amyloids—Functions and interactions within the host.Curr Opin Microbiol 16:93–99 .

             Indexed at, Google Scholar, Crossref

7. Wang WY, Tan MS, Yu JT, Tan L (2015). Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease.Ann Transl Med3:136.

              Indexed at, Google Scholar, Crossref

8. Schwab C, Klegeris A, McGeer PL (2010). Inflammation in transgenic mouse models of neurodegenerative disorders.Biochim Biophys Acta.1802:889-902.

              Indexed at, Google Scholar, Crossref